References
- Skinner D G, Lieskovsky G. Management of invasive and high-grade bladder cancer. Diagnostic and management of genitourinary cancer. W. B. Saunders & Co, New York 1988; 295, Chap. 16
- Raghavan D. The management of bladder cancer: Current practice and future prospects. The management of bladder cancer, Chap 17, D Raghavan. Edward Arnold, London 1988; 317–32
- Duncan W, Quilty P M. The results of a series of 963 patients with transitional cell carcinoma of the urinary bladder primarily treated by radical megavoltage X-ray therapy. Radiother Oncol 1986; 7: 299–310
- Carmichael J, Cornbleet M A, MacDougall R H. Cisplatin and methotrexate in the treatment of transitional cell carcinoma of the urinary tract. Br J Urol 1985; 57: 299–302
- Roberts J T, Fosså S D, Richards B. Results of medical research council phase II study of low dose cisplatin and methotrexate in the primary treatment of locally advanced (T3 and T4) transitional cell carcinioma of the bladder. Br J Urol 1991; 68: 162–8
- Ackland S P, Vogelzang N J. New drugs and old toxicities. The management of bladder cancer, Chap 10, D Raghavan. Edward Arnold, London 1988; 189–227
- Stoter G, Splinter T AW, Child J A. Combination chemotherapy with cisplatin and methotrexate in advanced transitional cell carcinoma of the bladder. J. Urol 1987; 137: 663–7
- Harker W G, Meyers F J, Freiha F S. An effective chemotherapy regimen for metastatic transitional cell carcinoma of the urinary tract. J Clin Oncol 1985; 3: 1463–70
- Sternberg C N, Yagoda A, Scher H I. M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for advanced transitional cell carcinoma of the urothelium. J Urol 1988; 139: 461–9
- TNM classification of malignant tumours, Third edition. UICC, Geneva 1978
- Bergkvist A, Ljungqvist A, Moberger G. Classification of bladder tumours based on the cellular pattern: preliminary report of a clinical-pathological study of 300 cases with a minimum follow-up of eight years. Acta Chi. Scand 1965; 130: 371–8
- Kirk J, Gray W M, Watson R. Cumulative radiation effect. Part 1: Fractionated treatment regimes. Clin Radiol 1971; 22: 145–55
- Rintala E, Hannisdahl E, Fosså S D, Hellsten S., Sander S. Neoadjuvant chemotherapy in bladder cancer: a randomized study. Scand J Urol Nephrol 1993; 27: 355–62
- Howard G CW, Cornbleet M A, Whillis D, Hargreave T B, Chisholm G D. Neoadjuvant chemotherapy with methotrexate and cisplatin prior to radiotherapy for invasive transitional cell carcinoma of the bladder. Assessment of feasibility and toxicity. Br J Urol 1991; 68: 490–4
- Shipley W U, Coombs L J, Einstein A B. Cisplatin and full-dose irradiation for patients with invasive bladder carcinoma: a preliminary report of tolerance and local response. J Urol 1984; 132: 899–903
- Bloom H JG, Hendry W F, Wallace D M, Skeet R G. Treatment of T3 bladder cancer: controlled trial of pre-operative radiotherapy and radial cystectomy versus radical radiotherapy. Br J Urol 1982; 54: 136